Mepolizumab improves small airway disease in severe eosinophilic asthmatics

被引：1
|
作者：
Cefaloni, Francesca [1 ]
Boccabella, Cristina [1 ]
Richeldi, Luca [2 ]
Bonini, Matteo [3 ,4 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Fdn Policlin Univ A Gemelli IRCCS, Dept Neurol ENT & Thorac Sci, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Fdn Policlin Univ A Gemelli IRCCS, Dept Neurol ENT & Thorac Sci,Natl Heart & Lung In, Rome, Italy
[4] Imperial Coll London, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4093
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4093
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mepolizumab improves small airway function in severe eosinophilic asthma
    Farah, Claude S.
    Badal, Tanya
    Reed, Nicola
    Rogers, Peter G.
    King, Gregory G.
    Thamrin, Cindy
    Peters, Matthew J.
    Seccombe, Leigh M.
    RESPIRATORY MEDICINE, 2019, 148 : 49 - 53
  • [2] Mepolizumab improves small airway function in severe eosinophilic asthma
    Seccombe, Leigh
    Rogers, Peter
    Reed, Nicola
    Badal, Tanya
    Thamrin, Cindy
    King, Greg
    Peters, Matthew
    Farah, Claude
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] SMALL AIRWAY FUNCTION IMPROVEMENT WITH MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Farah, C.
    Seccombe, L.
    Rogers, P.
    Reed, N.
    Badal, T.
    Thamrin, C.
    King, G.
    Peters, M.
    RESPIROLOGY, 2018, 23 : 213 - 213
  • [4] SMALL AIRWAY FUNCTION IMPROVEMENT WITH MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Rogers, P. G.
    Seccombe, L. M.
    Reed, N.
    Badal, T.
    Thamrin, C.
    King, G. G.
    Peters, M. J.
    Farah, C. S.
    RESPIROLOGY, 2018, 23 : 8 - 8
  • [5] Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma
    Taille, C.
    Hamidi, F.
    Heddebaut, N.
    Dupin, C.
    Le Guen, P.
    Le Brun, M.
    Pote, N.
    Cazes, A.
    Roy, C.
    Dupont, A.
    Letuve, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [6] Mepolizumab improves activity limitation in severe eosinophilic asthma
    Albers, Frank
    Nelsen, Linda M.
    Bratton, Daniel J.
    Bradford, Eric S.
    Braunstahl, G. J.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Pohl, Wolfgang
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis
    Sposato, B.
    Scalese, M.
    Camiciottoli, G.
    Carpagnano, G. E.
    Pelaia, C.
    Santus, P.
    Maniscalco, M.
    Corsico, A.
    Grosso, A.
    Baglioni, S.
    Murgia, N.
    Folletti, I
    Pelaia, G.
    Masieri, S.
    Cavaliere, C.
    Musarra, A.
    Bargagli, E.
    Ricci, A.
    Latorre, M.
    Rogliani, P.
    Paggiaro, P.
    RESPIRATORY MEDICINE AND RESEARCH, 2020, 78
  • [9] Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma
    Mullol, Joaquim
    Backer, Vibeke
    Constantinidis, Jannis
    Eguiluz-Gracia, Ibon
    Moure, Abraham L.
    Cuervo-Pinto, Rafael
    Zhang, Lingjiao
    Shah, Palvi
    Kerr, William
    Hellings, Peter
    RHINOLOGY, 2025, 63 (01)
  • [10] Mepolizumab reduces severe attacks and improves control in patients with severe eosinophilic asthmablood
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (12) : 668 - 668
12345